Get the Stockscreener App
1.71
7.55%
0.12
Pre-market:
1.73
0.02
+1.17%
Allurion Technologies Inc stock is traded at $1.71, with a volume of 81,520.
It is up +7.55% in the last 24 hours and up +0.59% over the past month.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
See More
Previous Close:
$1.59
Open:
$1.68
24h Volume:
81,520
Relative Volume:
0.45
Market Cap:
$20.96M
Revenue:
$34.75M
Net Income/Loss:
$-24.76M
P/E Ratio:
-0.1425
EPS:
-12
Net Cash Flow:
$-50.91M
1W Performance:
+6.21%
1M Performance:
+0.59%
6M Performance:
-40.21%
1Y Performance:
-80.23%
1-Day Range:
$1.56
$1.71
1-Week Range:
$1.365
$1.71
52-Week Range:
$1.02
$16.81
Allurion Technologies Inc Stock (ALUR) Company Profile
Name
Allurion Technologies Inc
Sector
Industry
Phone
508-647-4000
Address
11 HURON DR STE 200, NATICK
Compare ALUR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
1.71 | 19.49M | 34.75M | -24.76M | -50.91M | -12.00 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Oct-02-24 | Initiated | TD Cowen | Buy |
| Sep-06-24 | Initiated | ROTH MKM | Buy |
| Feb-09-24 | Initiated | Jefferies | Buy |
Allurion Technologies Inc Stock (ALUR) Latest News
How Allurion Technologies Inc. Warrants each stock behaves under inflation pressure2025 Top Gainers & Capital Efficient Trade Techniques - Newser
Why Allurion Technologies Inc. stock is a strong analyst pickWeekly Risk Summary & Safe Entry Momentum Stock Tips - Newser
Will Allurion Technologies Inc. Warrants each stock outperform Dow JonesQuarterly Performance Summary & Precise Entry and Exit Recommendations - Newser
How Allurion Technologies Inc. Equity Warrant stock valuations compare to rivalsMarket Activity Recap & Real-Time Market Trend Scan - Newser
How Allurion Technologies Inc. Warrants each stock responds to job market shiftsMarket Trend Summary & Accurate Trade Setup Notifications - Newser
Can Allurion Technologies Inc. Warrants each stock surprise markets with earnings2025 Stock Rankings & Consistent Profit Alerts - Newser
Why Allurion Technologies Inc. Equity Warrant stock is popular among millennialsPortfolio Value Summary & Weekly Setup with High ROI Potential - Newser
Is Allurion Technologies Inc. Warrants each stock a good hedge against inflation2025 Market Outlook & Safe Capital Growth Tips - Newser
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session - Benzinga
How Allurion Technologies Inc. stock benefits from strong dollarJuly 2025 Weekly Recap & Capital Efficiency Focused Strategies - Newser
Is Allurion Technologies Inc. Warrants each stock supported by free cash flowPortfolio Gains Summary & Reliable Price Breakout Alerts - Newser
How Allurion Technologies Inc. Warrants each stock valuation compares with sectorMarket Growth Report & Reliable Trade Execution Plans - Newser
Allurion reports 23% weight loss combining balloon with low-dose GLP-1 By Investing.com - Investing.com South Africa
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence - BioSpace
Allurion reports 23% weight loss, 14% lean mass gain on combining program with Tirzepatide - marketscreener.com
Allurion Reports 23% Weight Loss, 14% Lean Mass Gain On Combining Program With Tirzepatide - TradingView
Allurion reports 23% weight loss combining balloon with low-dose GLP-1 - Investing.com Australia
Allurion rises after strong weight-loss data from combination therapy - TradingView
Allurion (NYSE: ALUR) Posts 23% Weight Loss, 14% Lean Mass Gain With Low-Dose Tirzepatide - Stock Titan
Allurion Technologies (NYSE:ALUR) Given Neutral Rating at Chardan Capital - Defense World
Allurion Technologies’ (ALUR) Neutral Rating Reiterated at Chardan Capital - Defense World
Is the RiskReward Ratio Favorable for LWS Knitwear Limited in YEARTechnical Pattern Recognition & Reap the Rewards of Patience + Planning - earlytimes.in
Can Allurion Technologies Inc. Equity Warrant stock reach $100 price targetTrade Performance Summary & Smart Swing Trading Techniques - newser.com
Can Allurion Technologies Inc. Warrants each stock sustain revenue momentum - newser.com
Can Allurion Technologies Inc. stock hold up in economic slowdown2025 Volatility Report & Safe Capital Growth Plans - newser.com
Allurion Technologies’ Earnings Call: Progress Amid Challenges - MSN
Allurion Technologies Delays Q3 2025 Report Filing - MSN
Is Allurion Technologies Inc. Warrants each stock a buy for dividend portfoliosJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Allurion Smart Capsule shows 20% weight reduction in new study By Investing.com - Investing.com Nigeria
Chardan Capital Maintains Allurion Technologies (ALUR) Neutral Recommendation - Nasdaq
Allurion Smart Capsule shows 20% weight reduction in new study - Investing.com
New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone - The Joplin Globe
Allurion (NYSE: ALUR) Reports 20% Weight Loss, Better Body Composition at 36 Weeks - Stock Titan
Allurion Technologies (ALUR) Receives Neutral Rating Confirmatio - GuruFocus
Why millennials buy Allurion Technologies Inc. stockInsider Buying & Short-Term Trading Alerts - newser.com
Is Allurion Technologies Inc. Warrants each stock positioned for secular growth - newser.com
Will Allurion Technologies Inc. Warrants each stock return to pre crash levelsAnalyst Downgrade & Entry and Exit Point Strategies - newser.com
Is Allurion Technologies Inc. Equity Warrant stock a top momentum playWeekly Trade Recap & Verified Momentum Watchlists - newser.com
Can Allurion Technologies Inc. Equity Warrant stock sustain institutional interestJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com
Allurion Technologies Inc Stock (ALUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.89%
4.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):